Related Experiment Video
Updated: Mar 15, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
Long noncoding RNA SPRY4-IT1 promotes malignant development of colorectal cancer by targeting epithelial-mesenchymal
Dong Cao1, Qiong Ding1, Wubin Yu1
1Department of General Surgery, The People's Hospital of Putuo, Zhoushan.
Abstract:
The clinical significance and biological functions of long noncoding RNA SPRY4 intronic transcript 1 (SPRY4-IT1) in colorectal cancer (CRC) remain largely unclear. Herein, we are the first to report that the SPRY4-IT1 was significantly upregulated in CRC tissues, serum, and cells. Higher SPRY4-IT1 expression was markedly associated with advanced Tumor Node Metastasis (TNM) stage in a cohort of 84 CRC patients. Multivariate analyses indicated that SPRY4-IT1 expression could be useful as an independent predictor for overall survival. Further in vitro experiments revealed that knockdown of SPRY4-IT1 inhibited the proliferation, migration, and invasion of CRC cells and induced cell cycle arrestment. Moreover, we confirmed that the expression of epithelial-mesenchymal transition-related genes was modulated through alteration of SPRY4-IT1 expression. These results suggest that SPRY4-IT1, as an oncogenic regulator, may serve as a candidate prognostic marker and potential target for CRC therapies.
Insights
Long noncoding RNA SPRY4 intronic transcript 1 (SPRY4-IT1) is upregulated in colorectal cancer (CRC) and linked to advanced stages. SPRY4-IT1 inhibition suppresses CRC cell growth and metastasis, suggesting it as a prognostic marker.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The role of long noncoding RNA SPRY4 intronic transcript 1 (SPRY4-IT1) in colorectal cancer (CRC) is not well understood.
- SPRY4-IT1's clinical significance and biological functions in CRC require further investigation.
Purpose of the Study:
- To investigate the expression and functional role of SPRY4-IT1 in colorectal cancer.
- To evaluate SPRY4-IT1 as a potential prognostic biomarker and therapeutic target for CRC.
Main Methods:
- Quantitative real-time PCR to assess SPRY4-IT1 expression in CRC tissues, serum, and cells.
- Correlation analysis between SPRY4-IT1 expression and clinical parameters (e.g., TNM stage) in 84 CRC patients.
- In vitro functional assays (cell proliferation, migration, invasion, cell cycle analysis) after SPRY4-IT1 knockdown.
- Analysis of epithelial-mesenchymal transition (EMT)-related gene expression.
Main Results:
- SPRY4-IT1 was significantly upregulated in CRC tissues, serum, and cells compared to normal controls.
- Higher SPRY4-IT1 expression correlated with advanced Tumor Node Metastasis (TNM) stage.
- Multivariate analysis identified SPRY4-IT1 as an independent predictor of overall survival in CRC patients.
- Knockdown of SPRY4-IT1 inhibited CRC cell proliferation, migration, and invasion, and induced cell cycle arrest.
- SPRY4-IT1 alteration modulated the expression of EMT-related genes.
Conclusions:
- SPRY4-IT1 acts as an oncogenic regulator in colorectal cancer.
- SPRY4-IT1 is a potential prognostic marker for overall survival in CRC patients.
- SPRY4-IT1 represents a promising therapeutic target for colorectal cancer treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
RNA Splicing
Non-LTR Retrotransposons
Abnormal Proliferation
MicroRNAs